US Executive Officer Management Changes SEC — June 01, 2026

01-06-2026

Lucid Group, Inc. announced that Silvio Napoli has assumed the role of CEO effective June 1, 2026, following a leadership transition previously announced on April 14. Marc Winterhoff, who served as Interim CEO, has resumed his role as Chief Operating Officer and will report to Napoli. The new CEO emphasized a focus on strengthening customer engagement, cost competitiveness, and streamlining operations.

• · Silvio Napoli was previously announced as incoming CEO on April 14, 2026.
• · Napoli most recently served as Chairman and CEO of Schindler Group, bringing experience in global operations and technology-driven businesses.
• · Marc Winterhoff had served as Interim CEO before resuming his role as COO.

01-06-2026

On May 27, 2026, Thomas Earl, Chief Commercial Officer of VG LNG Marketing, LLC (UK Branch), an indirect wholly-owned subsidiary of Venture Global, Inc., notified the company he will step down from his executive role effective June 1, 2026. He will remain an employee in a non-executive capacity for one year. Internal personnel have been identified to assume his duties.

• · Thomas Earl's resignation is effective June 1, 2026.
• · He will remain an employee in a non-executive capacity for a term of one year.
• · Internal personnel have been identified to assume his previous duties and responsibilities.
• · The filing was signed by Jonathan Thayer, Chief Financial Officer, on May 29, 2026.

01-06-2026

Science Applications International Corp (SAIC) announced the departure of Srinivas Attili, Executive Vice President, Civilian Business Group, effective May 29, 2026, with his final departure on or about June 12, 2026. The departure is in connection with an internal reorganization. Mr. Attili will receive severance compensation under the company's Executive Severance, Change in Control and Retirement Policy, subject to a release of claims and a two-year non-compete agreement. No financial figures or period-over-period comparisons are provided in this filing.

• · Mr. Attili stepped down from his role on May 29, 2026, and will depart the company on or about June 12, 2026.
• · Severance compensation is pursuant to Section 5 of the company's Executive Severance, Change in Control and Retirement Policy.
• · The severance requires execution and non-revocation of a release of claims and a two-year post-employment non-compete obligation.

01-06-2026

On May 31, 2026, Tawn Kelley resigned as Chair and a member of the Board of Directors of Champion Homes, Inc., effective immediately, with no disagreement with the company or its management. The Board appointed Michael Berman as Chair and Gary Robinette as Chair of the Nominating and Governance Committee, and reduced the Board size from seven to six directors.

• · Tawn Kelley's resignation was not due to any disagreement with the company or its management.
• · The Board decreased its size from seven to six directors.

01-06-2026

Regal Rexnord announced the appointment of Mark Klossner as EVP & President of Industrial Powertrain Solutions (IPS), effective immediately, succeeding Jerry Morton who will retire on December 31, 2026. Klossner, who joined via the Altra acquisition in 2023, previously led the Couplings and Gearing Divisions with an approximately $1.4B portfolio. The leadership transition reflects internal succession planning, with Morton staying on as EVP until retirement to ensure a smooth handover.

• · Jerry Morton will retire after 11 years with Regal Rexnord and a 39-year career in power transmission, which joined the company via the Emerson acquisition in 2015.
• · Morton served as EVP & President of IPS since 2023 and will remain as EVP until December 31, 2026.
• · Klossner holds an MBA from Kellogg School of Management, a Master of Engineering Management from Northwestern, and a B.S. in Materials Science and Engineering from Cornell.
• · Regal Rexnord operates three segments: Automation & Motion Control, Industrial Powertrain Solutions, and Power Efficiency Solutions.
• · End markets include discrete automation, food & beverage, aerospace & defense, medical, data center, energy, residential and commercial buildings, general industrial, and metals and mining.

01-06-2026

Athene Holding Ltd. announced the appointment of Matthew Michelini as President, effective July 1, 2026, to drive strategic growth initiatives including reinventing guaranteed lifetime income solutions. Michelini, who has been with Apollo for nearly 20 years and most recently served as Head of Asia-Pacific, will focus on alignment across Athene and expansion into new markets. The company reported total assets of $448 billion as of March 31, 2026, but the filing does not include any financial performance metrics or period-over-period comparisons.

• · Michelini joined Apollo in 2006 and has been with the firm for nearly 20 years.
• · He previously served on the Boards of Athene Holding Ltd. and several other companies.
• · Before Apollo, Michelini was a member of the Mergers & Acquisitions group at Lazard Frères & Co.
• · Athene has operations in the United States, Bermuda, Canada, and Japan.

01-06-2026

Dmitri Stockton notified Deere & Company's Board on May 26, 2026, that he will not stand for re-election as a director at the 2027 annual meeting. He will serve the remainder of his current term, which expires at the 2027 meeting, and his decision is not due to any disagreement with the company. The Board thanked him for nearly 12 years of service.

• · Mr. Stockton's decision is not the result of any disagreement with the company, its operations, policies, or practices.
• · The Board looks forward to his continued service through the 2027 annual meeting.

01-06-2026

ContextLogic Holdings Inc. (OTCQB: LOGC) announced the appointment of Scott Stewart as Chief Financial Officer and Chief Operating Officer, effective June 1, 2026. Mr. Stewart brings extensive experience in acquisitions, integration, and financial infrastructure from his roles at Cantaloupe, Inc. and Intercontinental Exchange. The filing contains no financial results or period-over-period comparisons, so no quantitative performance metrics are available.

• · Mr. Stewart previously served as CFO of Cantaloupe, Inc. (Nasdaq: CTLP), a technology and payments company.
• · He spent 13 years at Intercontinental Exchange, Inc., a Fortune 500 company that owns equity and commodity exchanges including the NYSE.
• · During his tenure at ICE, he supported more than 30 acquisitions and integrations, including the landmark acquisition of the NYSE.
• · Earlier in his career, Mr. Stewart spent four years at Ernst & Young in their audit practice.
• · He holds a Bachelor of Science in Accounting and a Master of Professional Accountancy from Clemson University.
• · The filing includes forward-looking statements regarding the Company's plans to acquire businesses, integrate them, and build financial infrastructure.

01-06-2026

CVB Financial Corp. (CVBF) entered into a Third Amended and Restated Employment Agreement with CEO David A. Brager on June 1, 2026, extending his term through June 30, 2029. The agreement maintains his base salary at $966,000 and provides a target bonus of 120% of base salary, with a maximum of 180%, along with annual equity grants expected at 180% of base salary. The early renewal, originally set to expire in 2027, reflects the Board's confidence in Mr. Brager's leadership, but the extended term and enhanced severance provisions (including 2.5x pay upon change-in-control) increase the company's long-term compensation commitments.

• · Mr. Brager has been employed by the company since 2003 and served as Executive Vice President and Sales Division Manager from 2010 to 2020.
• · The agreement includes a monthly automobile allowance of $2,000 and reimbursement for one country club and one social club membership.
• · Upon death or permanent disability, all unvested options, Time RSUs, and Performance RSUs vest in full (Performance RSUs at target).
• · Severance benefits are conditioned upon execution of a release of claims in favor of the company.
• · The agreement provides for successive one-year renewal terms after June 30, 2029, unless terminated by either party.

01-06-2026

Gulfport Energy Corp announced the appointment of Domenic J. Dell'Osso, Jr. as a Board member effective May 28, 2026, following his appointment as President and CEO on May 4, 2026. The company also granted restricted stock units worth $222,500 to SVP Michael Sluiter, and stockholders ratified all proposals at the 2026 Annual Meeting, including the election of six directors and approval of say-on-pay. No negative or flat metrics were reported in this filing.

• · Dell'Osso will receive no additional compensation for his Board role.
• · Dell'Osso served as CEO of Expand Energy from 2021 to February 2026, where the company became the largest U.S. natural gas producer.
• · Dell'Osso holds an MBA in Finance from UT Austin and a BA in Economics from Boston College.
• · Stockholders ratified Grant Thornton LLP as independent auditors for FY2026 with 15,096,966 votes for, 245,452 against, and 38,986 abstentions.
• · Say-on-pay proposal passed with 14,813,750 votes for, 289,761 against, and 47,047 abstentions.
• · All six director nominees were elected with votes ranging from 14,761,123 to 14,955,006 in favor.
• · Broker non-votes totaled 230,828 for each director election and the say-on-pay proposal.

01-06-2026

Hanover Bancorp, Inc. held its annual shareholder meeting on May 28, 2026, where shareholders elected three directors for three-year terms (Michael Katz, John R. Sorrenti, and Philip Okun) and approved the 2026 Equity Incentive Plan. The appointment of Crowe LLP as the independent auditor for fiscal year 2026 was also ratified. All proposals passed with strong shareholder support, though there were 903,723 broker non-votes on the director election and equity plan proposals.

• · The 2026 Equity Incentive Plan was approved with 4,755,228 FOR votes, 27,522 AGAINST, and 43,684 ABSTAIN.
• · Ratification of Crowe LLP as independent auditor received 5,725,927 FOR, 2,908 AGAINST, and 1,322 ABSTAIN, with no broker non-votes.
• · There were 903,723 broker non-votes on both the director election and the equity plan proposal.

01-06-2026

Microchip Technology appointed Mitch Little, former Senior Vice President of Worldwide Client Engagement, to its Board of Directors effective June 1, 2026. Mr. Little is considered an independent director under Nasdaq rules and will receive the standard non-employee director compensation. He was not appointed to any board committee.

• · Mr. Little retired from Microchip effective May 31, 2022.
• · He founded CUSP Advisory Group and authored two books on client value and leadership.
• · There are no arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K.
• · Director compensation details are referenced in Microchip's definitive proxy statement filed July 7, 2025.

01-06-2026

Penguin Solutions, Inc. announced that CFO Nate Olmstead will step down on July 8, 2026, to pursue an opportunity in another industry, and will be succeeded by Aaron Johnson as Interim CFO effective July 9, 2026. The company reaffirmed its full-year fiscal 2026 outlook, expecting both net sales and diluted EPS at the high end of previously issued ranges, driven by strong agentic AI-driven demand. The company has initiated a search for a permanent CFO with the support of a leading executive search firm.

• · Olmstead's departure is not due to any disagreement with the company on operating performance, financial reporting, accounting, internal controls, operations, policies, or practices.
• · The company expects to report Q3 fiscal 2026 results on July 7, 2026.
• · Penguin Solutions is headquartered in Silicon Valley, California and operates globally through R&D, manufacturing, and sales locations.

01-06-2026

ProPetro Holding Corp. announced the resignation of director Alex V. Volkov from its Board, effective May 28, 2026, following the sale by Pioneer Natural Resources Pumping Services LLC (an Exxon Mobil subsidiary) of all its remaining outstanding shares of the company on May 20, 2026. The Board size was reduced from eight to seven directors, and Pioneer no longer retains the right to designate board nominees. The resignation was not due to any disagreement with management or the Board.

• · Pioneer sold all its remaining outstanding shares of ProPetro on May 20, 2026.
• · The resignation was not due to any disagreement with management or the Board.
• · Pioneer no longer has the right to designate nominees for election to the Board.

01-06-2026

Valmont Industries entered into a separation and release agreement with former CFO Thomas Liguori on May 26, 2026, formalizing his retirement. Liguori will provide consulting services until December 26, 2026, receiving base salary, benefits, and accelerated vesting of equity awards, but no new incentive grants. The agreement includes confidentiality and restrictive covenants.

• · Liguori's retirement effective April 8, 2026, with consulting through December 26, 2026.
• · Accelerated vesting of restricted stock units and stock options on December 26, 2026.
• · Cash payment includes severance (20 weeks base salary plus 2 weeks for service), 2026 short-term incentive, and performance stock unit awards under 2024-2026, 2025-2027, and 2026-2028 plans.
• · Incentive payouts no later than March 15, 2027.
• · Liguori not eligible for new incentive grants.

01-06-2026

Verra Mobility announced a CEO transition, with David Roberts stepping down immediately and Jon Keyser appointed interim President and CEO. The Board cited a need for leadership change to realign cost structure and position for future growth, while a search for a permanent CEO is underway. The company faces a dynamic market and is taking decisive actions to reduce costs and strengthen customer relationships.

• · Jon Keyser has served as Chief Transformation Officer since 2025, driving cost optimization and streamlining business processes.
• · David Roberts had led the company for 12 years, including taking it public.
• · The Board has retained a leading global executive search firm to identify the next CEO, considering both internal and external candidates.
• · Jon Keyser previously served as Vice President and General Counsel of Honeywell Performance Materials and Technologies and as Assistant General Counsel at Harley-Davidson.
• · Jon Keyser is a former intelligence officer in the United States Air Force with combat deployments in Iraq and Afghanistan.

01-06-2026

TechnipFMC appointed Eric D. Mullins, Chairman and CEO of Lime Rock Resources, to its Board of Directors effective June 1, 2026. Mullins brings extensive energy sector experience, public company board expertise, and financial acumen from his 15-year tenure at Goldman Sachs. The filing does not disclose any financial metrics or performance data.

• · Eric D. Mullins co-founded Lime Rock Resources in 2005 and has jointly led the firm since inception.
• · Prior to Lime Rock, Mullins spent 15 years at Goldman Sachs in the Natural Resources Group, including as managing director.
• · Mullins currently serves on the board of Valero Energy Corporation and on the boards of trustees of Baylor College of Medicine and the Greater Houston Partnership.
• · He previously served on the boards of Anadarko Petroleum, PG&E Corporation, ConocoPhillips, and LRR Energy.
• · Mullins holds a bachelor's degree from Stanford University and an MBA from the Wharton School.
• · TechnipFMC is organized into two business segments: Subsea and Surface Technologies.
• · The company uses its website as a channel for distributing material company information.

01-06-2026

Sirius XM Holdings Inc. held its 2026 Annual Meeting on May 28, 2026, where stockholders approved Amendment No. 1 to the 2024 Long-Term Stock Incentive Plan, increasing the aggregate shares available for awards by 7,200,000 to a total of 22,565,993 shares. All director nominees were elected, and the advisory vote on executive compensation and ratification of KPMG LLP as independent auditor for 2026 were also approved. However, the vote tallies show significant broker non-votes (51,448,019) across most items, and some directors received notable votes withheld (e.g., Jonelle Procope with 23,500,101 votes withheld).

• · The 2026 Annual Meeting was held on May 28, 2026, and the Form 8-K was filed on June 1, 2026.
• · All director nominees were elected, but Jonelle Procope received 23,500,101 votes withheld (10.0% of votes cast), and Anjali Sud received 21,244,073 votes withheld (9.1% of votes cast).
• · The advisory vote on executive compensation passed with 228,280,853 votes for, but 4,764,836 votes against and 1,349,137 abstentions.
• · Amendment No. 1 to the 2024 Plan was approved with 224,632,532 votes for, 8,579,820 against, and 1,182,474 abstentions.
• · Ratification of KPMG LLP as independent auditor for 2026 received 281,049,339 votes for, 2,379,515 against, and 2,413,991 abstentions.
• · Broker non-votes totaled 51,448,019 for director elections and Items 2 and 3, indicating significant shares not voted by brokers.

01-06-2026

AtlasClear Holdings, Inc. filed an 8-K on June 1, 2026, reporting that stockholders approved a first amendment to the company's 2024 Equity Incentive Plan on May 27, 2026. The amendment increases the number of shares authorized for issuance under the plan by 15,000,000 shares of common stock. The filing does not include any financial results or performance metrics, so no positive or negative trends can be assessed.

• · The Plan Amendment was previously approved by the board of directors, subject to stockholder approval.
• · A detailed summary of the Plan and Plan Amendment appears on pages 13–20 of the definitive proxy statement filed April 30, 2026, as supplemented on May 12, 2026.
• · The amendment is filed as Exhibit 10.1 to the 8-K.

01-06-2026

Esperion Therapeutics held its 2026 annual meeting on May 28, 2026, where stockholders approved all four proposals: the election of Class I directors J. Martin Carroll and Sheldon L. Koenig, the non-binding advisory vote on executive compensation, the ratification of Ernst & Young LLP as independent auditor for FY2026, and an amendment to the 2022 Stock Option and Incentive Plan to increase authorized shares by 7,000,000. The meeting had a quorum of 177,208,856 shares out of 257,404,876 outstanding. While all proposals passed, the advisory vote on executive compensation (Proposal 2) received only 72.9% support, with 26.6% against, indicating notable shareholder dissent.

• · Record date for the annual meeting was March 31, 2026.
• · Broker non-votes were 46,114,802 on Proposals 1, 2, and 4, but zero on Proposal 3 (auditor ratification).
• · Proposal 3 (auditor ratification) received the highest support: 167,083,447 For, 8,765,273 Against, 1,360,136 Abstain.
• · Sheldon L. Koenig received 109,672,941 For votes vs. J. Martin Carroll's 105,082,565 For votes.
• · The Plan Amendment (Proposal 4) passed with 108,150,213 For, 22,489,001 Against, 454,840 Abstain.

01-06-2026

The Trade Desk announced the appointment of Nate Olmstead as Chief Financial Officer, effective July 9, 2026, succeeding interim CFO Tahnil Davis, who will return to her previous role as Chief Accounting Officer. Olmstead brings extensive financial leadership experience from Penguin Solutions, Logitech, and Hewlett Packard. The change is positioned to support the company's continued growth and profitability, with no negative or flat metrics reported in the filing.

• · Nate Olmstead's appointment as CFO is effective July 9, 2026.
• · Olmstead will report directly to CEO Jeff Green.
• · Tahnil Davis has been with The Trade Desk for 11 years and will continue as Chief Accounting Officer, reporting to Olmstead.
• · Olmstead previously served as SVP and CFO of Penguin Solutions and CFO of Logitech International S.A.
• · Olmstead spent 16 years in financial leadership roles at Hewlett Packard Company and Hewlett Packard Enterprise.

01-06-2026

West Pharmaceutical Services announced the appointment of Michel Lagarde as President and CEO effective August 31, 2026, succeeding Eric M. Green who will retire. The Board also elected Lead Independent Director Robert F. Friel as Board Chair. Lagarde brings extensive experience from Thermo Fisher Scientific and Patheon, and the company reported FY2025 net sales of $3.07 billion.

• · Michel Lagarde previously served as EVP and COO at Thermo Fisher Scientific, joining through the acquisition of Patheon N.V.
• · Lagarde holds a BBA from European University in Antwerp and an executive master's in finance and control from Maastricht University.
• · West has over 10,000 team members across 50 sites, including 26 manufacturing facilities worldwide.
• · The company delivers over 41 billion components and devices each year.
• · West is included on the S&P 500 index.

01-06-2026

On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from the board of directors of Seres Therapeutics, Inc., effective May 31, 2026. The resignation is not due to any disagreement with the company regarding its operations, policies, or practices.

• · Dr. Woerle's resignation is effective May 31, 2026.
• · He also resigned from all committees on which he served.
• · The departure is explicitly stated as not due to any disagreement with the company.

01-06-2026

LP Building Solutions (LPX) announced the retirement of Executive Vice President and CFO Alan Haughie, effective September 1, 2026, with Aaron Howald appointed as his successor. Haughie will remain in an advisory capacity through February 2027 to ensure a smooth transition. The change is part of a planned succession and does not reflect any negative financial or operational performance.

• · Alan Haughie joined LP in 2019 as Executive Vice President and CFO.
• · Aaron Howald has been with LP for 15 years, most recently as Vice President, Investor Relations and Business Development.
• · Howald holds an MBA from Indiana University Kelley School of Business and a BA in Finance and Economics from Franklin College.
• · LP operates more than 20 manufacturing facilities across North and South America.
• · The company was founded in 1972 and is headquartered in Nashville, Tennessee.

01-06-2026

Sera Prognostics announced that board member Jeff Elliott will step down effective June 4, 2026, and will not stand for re-election. The company is in advanced discussions with qualified candidates to fill the vacancy. No financial impact was disclosed.

• · Jeff Elliott served on the board since March 2025.
• · The company expects to announce a new board appointment in the near term.
• · The PreTRM Test is the only broadly validated blood-based biomarker test for preterm birth risk prediction.

01-06-2026

GEE Group Inc. (NYSE American: JOB) announced the resignation of Director Darla Moore, effective June 1, 2026, due to time commitments from her existing and new business endeavors. Ms. Moore had served on the Board since 2018 and chaired the Governance and Nominating Committees, also serving on the Audit, M&A, and Compensation Committees. The resignation was not due to any disagreement with the Company. No financial impact or performance metrics were disclosed in this filing.

• · Darla Moore had been a Board member since 2018, serving for 8 years.
• · She chaired the Governance and Nominating Committees and was a member of the Audit, M&A, and Compensation Committees.
• · The Company reiterated forward-looking statements and risk factors, including potential impacts from pandemics, economic conditions, and competition.

01-06-2026

Salesforce held its 2026 Annual Meeting on May 28, 2026, where all 13 director nominees were elected, and stockholders approved amendments to the 2013 Equity Incentive Plan (adding 34 million shares) and the 2004 Employee Stock Purchase Plan. The advisory vote on executive compensation passed with 79.5% support, while a shareholder proposal on cumulative voting was overwhelmingly rejected. Notably, several directors received significant against votes, including John V. Roos (6.6% against), Mason Morfit (5.8% against), and Robin Washington (5.9% against).

• · Directors with highest against votes: John V. Roos (40,064,925 against), Mason Morfit (35,106,845 against), Robin Washington (36,317,035 against).
• · Ratification of Ernst & Young as auditor passed with 663,734,521 for, 49,972,013 against.
• · Amendment to 2004 Employee Stock Purchase Plan passed with 609,941,606 for, 1,918,316 against.
• · Broker non-votes were 102,463,325 for all director elections and most proposals except auditor ratification.

01-06-2026

CorVel Corp announced a leadership transition: Sarah Scott will become CEO and President effective July 1, 2026, succeeding Michael G. Combs, who will become Executive Chair. Scott has over 26 years at CorVel and currently serves as EVP of Product and Corporate Services. The change reflects the company's long-term succession planning, but no financial metrics or performance data were disclosed in this filing.

• · Sarah Scott has served CorVel for more than 26 years and is currently Executive Vice President, Product and Corporate Services.
• · Michael G. Combs has served as President since 2017 and CEO since 2019.
• · Jeff Michael is a member of the Board of Directors and the company's largest shareholder.
• · The transition is effective July 1, 2026.

01-06-2026

Select Water Solutions, Inc. announced that effective June 1, 2026, Michael C. Skarke transitioned from Executive Vice President and Chief Operating Officer to Executive Vice President and Chief Commercial Officer. He will focus on building out water infrastructure networks and developing other businesses, including recent acquisitions. The company does not plan to appoint a replacement COO, and business segment leaders will now report directly to the CEO; no compensation changes were made.

• · Mr. Skarke continues to serve as an executive officer and reports to the CEO.
• · No replacement COO will be appointed; business segment leaders will report directly to the CEO.
• · No adjustment to Mr. Skarke's compensation arrangements as a result of the change.

01-06-2026

On May 29, 2026, the Compensation Committee of Aeva Technologies, Inc. approved 2025 cash bonuses for named executive officers. CEO Soroush Salehian Dardashti and President/CTO Mina Rezk each received the maximum target bonus under their employment agreements, while CFO Saurabh Sinha received the target amount. No specific bonus amounts or performance metrics were disclosed.

• · The cash bonuses for 2025 were not determined at the time of the filing of the Company’s definitive proxy statement, necessitating this 8-K filing.
• · The bonuses were approved by the Compensation Committee of the Board of Directors.
• · The filing is made under Item 5.02 of Form 8-K, relating to departure/election of directors or officers and compensatory arrangements.

01-06-2026

Charlotte's Web Holdings, Inc. announced shareholder approval of a transaction with British American Tobacco (BAT) at its May 28, 2026 annual meeting, which will result in the issuance of 109,944,042 common shares to BAT (40.6% of the post-closing total). The transaction is expected to close on or about May 28, 2026, subject to TSX approval, and is intended to strengthen the balance sheet and simplify capital structure. However, the significant dilution (40.6% of shares) and the fact that 27% of votes were withheld for director Angela McElwee indicate notable shareholder dissent.

• · The meeting was held via live audio webcast on May 28, 2026.
• · The proxy statement was dated April 16, 2026.
• · The convertible debenture was originally issued on November 14, 2022.
• · The transaction is subject to final TSX approval and customary closing conditions.
• · The company is a Certified B Corporation headquartered in Louisville, Colorado.
• · Shares trade on TSX under symbol CWEB and on OTCQX under CWBHF.

01-06-2026

Alpha Teknova, Inc. announced the retirement of director Irene Davis, effective as of the 2026 Annual Meeting, and reduced the Board size from eight to seven directors. At the Meeting on June 1, 2026, stockholders re-elected J. Matthew Mackowski and Brett Robertson as Class II directors and ratified the appointment of Grant Thornton LLP as auditor for fiscal year 2026. The changes are routine governance matters with no reported operational disagreements.

• · The Board reduced its size from eight to seven directors effective June 1, 2026, and the number of Class II directors from three to two.
• · Existing director Ms. Demski was appointed to the Nominating and Corporate Governance Committee to fill the vacancy left by Ms. Davis.
• · Irene Davis's retirement was due to personal and professional interests and not from any disagreement with the Board or Company.
• · The 2026 Annual Meeting was held on June 1, 2026.

01-06-2026

Carlyle Group Inc. announced the appointment of Kate Heinzelman as General Counsel, effective June 29, 2026, succeeding Jeffrey Ferguson who will transition to a Senior Advisor role. Heinzelman brings extensive legal experience from the CIA, DOJ, and private practice. The filing also notes Carlyle's AUM of $475 billion as of March 31, 2026, and a workforce of over 2,500 employees.

• · Kate Heinzelman will be based in Washington, D.C.
• · Heinzelman served as General Counsel of the CIA from July 2022 to January 2025.
• · Jeffrey Ferguson served as General Counsel since 1999 and will become Senior Advisor effective June 29, 2026.
• · Carlyle operates 28 offices across four continents.
• · The filing includes forward-looking statements and references risk factors in the 2025 Form 10-K.

01-06-2026

Sonida Senior Living appointed Anton Nikodemus as its first Chief Operating Officer, effective June 15, 2026. Nikodemus brings 30 years of hospitality and operations experience from Seaport Entertainment Group and MGM Resorts International. The appointment aims to accelerate scalability, elevate resident experience, and drive margin expansion using the company's proprietary SPIN operating platform.

• · Nikodemus previously served as President, CEO, and Chairman of Seaport Entertainment Group, leading its spin-off from Howard Hughes Holdings and NYSE listing.
• · He spent 18 years at MGM Resorts International, culminating as President and COO of CityCenter, overseeing AAA Five Diamond properties.
• · Nikodemus holds a BS in Business Management and Marketing from Arizona State University and is a graduate of the Wharton Advanced Executive Finance Program.
• · Sonida manages or is invested in 165 senior housing communities with over 16,400 units across 35 states.

01-06-2026

Dycom Industries reported the retirement of directors Laurie J. Thomsen and Luis Avila-Marco effective May 28, 2026, reducing the board from 11 to 9 members. Shareholders elected four directors, approved executive compensation on an advisory basis, and ratified PricewaterhouseCoopers as auditor for fiscal 2027. All proposals passed with strong support, though Peter T. Pruitt, Jr. received a notable 3.1% against vote.

• · The 2026 Annual Meeting was held on May 28, 2026.
• · Luis Avila-Marco notified the board of his decision not to stand for reelection on December 18, 2025.
• · Retirements were not due to any disagreement with the company.
• · Proposal 2 (executive compensation) received 24,341,198 votes for, 743,277 against, 19,575 abstain.
• · Proposal 3 (auditor ratification) received 26,812,913 votes for, 100,053 against, 15,028 abstain, with no broker non-votes.

01-06-2026

BCB Bancorp, Inc. appointed Thomas M. O'Brien as President and CEO effective June 1, 2026, succeeding the prior leadership amid recent operational and credit challenges. Chairman Mark D. Hogan cited the need to accelerate improvement efforts, while O'Brien plans an aggressive program to address legacy credit portfolio costs and industry pressures, with clarity expected by late summer.

• · O'Brien previously served as CEO of six different banking companies over 48 years, most recently at Sterling Bank & Trust.
• · He previously served as President and CEO of Sun Bancorp, Inc. and Sun National Bank from April 2014 to February 2018.
• · BCB Community Bank has 23 branches in New Jersey and 4 branches in New York (Hicksville and Staten Island).
• · A conference call for investors is scheduled for June 1, 2026 at 8:45 a.m. ET (dial-in: 1 (929) 205-6099, Meeting ID 967 4541 1737, Passcode 408368).
• · O'Brien anticipates providing meaningful clarity on plans by late summer.

01-06-2026

Fusemachines Inc. appointed renowned AI researcher Dr. Julia Hirschberg to its Board of Directors, effective June 1, 2026. Concurrently, current Board Director Sanjay Shrestha stepped down from the Board but will continue as a member of the Board of Advisors. The appointment strengthens the company's governance and AI expertise, though no financial metrics or performance data were disclosed.

• · Dr. Hirschberg is the Percy K. and Vida L. W. Hudson Professor of Computer Science at Columbia University and previously served as Chair of the Department of Computer Science.
• · She is a member of the National Academy of Engineering, American Academy of Arts and Sciences, and National Academy of Artificial Intelligence, and holds two Ph.D. degrees and two honorary doctorates.
• · She previously founded the Human Computer Interface Research Department at AT&T Bell Labs.
• · Sanjay Shrestha will continue to support the company as a member of its Board of Advisors.
• · Fusemachines serves companies in retail, manufacturing, and government sectors.

01-06-2026

Aditxt, Inc. (ADTX) appointed Jeffrey M. Busch as Interim CEO effective May 31, 2026, replacing founder Amro Albanna who resigned as CEO and board member. Mr. Busch previously founded a NYSE-listed healthcare REIT (Global Medical REIT/GMRE) that he built to over $1 billion in enterprise value while delivering ~8.5% average dividend yield to shareholders. The company plans to accelerate commercialization of its Ignite Proteomics precision oncology diagnostics platform under the new leadership. While the press release is optimistic about Busch's background and the strategic priorities, the filing does not disclose any financial figures for Aditxt itself, nor does it address the company's current liquidity, revenue trajectory, or going concern risks — significant uncertainties typical for a small-cap life sciences company with no disclosed dividend policy and a volatile stock (Nasdaq: ADTX).

• · Aditxt does not currently have a dividend policy and has no current plan or intention to declare cash dividends — the 8.5% dividend yield reference relates solely to Busch's prior role at GMRE, not Aditxt.
• · Busch has served as CEO of Ignite Proteomics since March 2026 and will continue both roles.
• · The outgoing CEO Amro Albanna resigned as CEO, from the board, and from all subsidiary positions — he co-founded Aditxt and led the company through its public listing and acquisition strategy.
• · Aditxt's strategic priorities under new leadership are: patients first, revenue-driven innovation, stakeholder responsibility, and capital market engagement.
• · Ignite Proteomics holds a Medicare PLA code for its RPPA-based precision oncology tests and has clinical collaborations with Dana-Farber Cancer Institute and Vanderbilt University Medical Center.
• · The press release provides no current financial data for Aditxt (no revenue, cash balance, debt, or operating metrics).

01-06-2026

Rapid7 announced a leadership transition where board member Wael Mohamed becomes CEO, succeeding Corey Thomas who becomes Executive Chairman, effective immediately. The company reaffirmed its Q2 and full-year 2026 financial guidance. Mohamed brings 30 years of cybersecurity experience, while Thomas will focus on technology vision and AI strategy.

• · Rapid7 recently acquired Kenzo, an AI security platform.
• · Senior leadership team refreshed with Rafe Brown as CFO, Allan Peters as CCO, and Dan Deklich as CPTO.
• · Mohamed founded Global Forward Capital, a cybersecurity investment firm.
• · Thomas served as CEO for over 13 years, leading Rapid7 through its IPO.
• · Thomas serves on boards of LPL Financial, Blue Cross Blue Shield of Massachusetts, Vanderbilt University, and Greater Boston Chamber of Commerce.

01-06-2026

LIXTE Biotechnology Holdings, Inc. announced a strategic transformation from a clinical-stage pharmaceutical company into an AI energy infrastructure equipment & services platform focused on meeting power demands of AI and hyperscale data centers. The company also appointed Stuart D. Porter, Founder of Denham Capital, to its Board of Directors and stated it will seek a strategic acquisition partner for its pharmaceutical and med-tech operations. No financial performance metrics or comparative period data were provided as this is a forward-looking strategic announcement.

• · NERC issued a rare Level 3 Alert in April 2026 directing grid operators to address reliability risks tied to large-scale computational loads.
• · Denham Capital’s infrastructure group is advancing a U.S. & European pipeline of roughly 10 GW of AI data-center-oriented power generation asset opportunities.
• · LIXTE expects to maintain its Nasdaq listing under ticker 'LIXT' during the transformation process.
• · The company's lead compound LB-100 is in proof-of-concept clinical trials for Ovarian Clear Cell Carcinoma, Metastatic Colon Cancer and Advanced Soft Tissue Sarcoma.
• · Liora Technologies Europe Ltd. is a wholly owned subsidiary pioneering electronically controlled proton therapy systems.

01-06-2026

BT Brands, Inc. announced that Kenneth Brimmer resigned as CFO, principal financial officer, and principal accounting officer, and as a Board member, effective May 26, 2026. The resignation was not due to any disagreement with the company, its management, or board. No successor has been appointed yet.

• · Brimmer held roles as CFO, principal financial officer, and principal accounting officer.
• · Resignation effective May 26, 2026.
• · The filing was signed and dated May 29, 2026, by CEO Gary Copperud.
• · The company checked boxes indicating written communications under Rule 425 and soliciting material under Rule 14a-12.
• · Securities listed on Nasdaq Capital Market: common stock (BTBD) and warrants (BTBDW).

01-06-2026

Medifast, Inc. announced the resignation of Jason L. Groves, Chief Legal Officer & Corporate Secretary, effective May 29, 2026. The departure was not due to any disagreement with the company or its operations. A separation agreement provides for a one-month base salary severance payment, and a search for a permanent replacement has commenced.

• · Mr. Groves' resignation was effective May 29, 2026.
• · The separation agreement was entered into on May 31, 2026.
• · Severance is a one-time lump sum equal to one month of annual base salary, subject to non-revocation and compliance with the agreement.
• · The company has begun a search for a permanent replacement.

01-06-2026

Norfolk Southern appointed Brian Barr as Chief Operating Officer effective June 1, 2026, succeeding John Orr who will retire. Orr will serve as special advisor through June 30, 2026, and continue as advisor to the Chair through the earlier of the Union Pacific merger closing or June 1, 2027. The filing also mentions the pending Union Pacific merger.

• · Brian Barr joined Norfolk Southern in September 2024 and led the Mechanical department for two years.
• · Barr previously held leadership roles at CSX and Union Pacific, including SVP Transportation.
• · John Orr will retire effective July 1, 2026, but will continue as special advisor to the Chair through the earlier of the Union Pacific merger closing or June 1, 2027.
• · Norfolk Southern serves a majority of the U.S. population and manufacturing base, with connections to every major container port on the Atlantic coast and major ports across the Gulf Coast and Great Lakes.

01-06-2026

Revium Rx. announced the resignation of CFO Arie Gordashnikov effective May 27, 2026, with no disagreement cited, and the immediate appointment of Igor Bluvstein as his replacement. Mr. Bluvstein, a CPA with over 17 years of financial leadership experience in pharmaceutical and biotech firms, will receive a monthly retainer of NIS17,000 plus VAT. The filing does not disclose any financial performance metrics, so no period-over-period comparisons are available.

• · Mr. Gordashnikov's resignation was not due to any disagreement with the company.
• · Mr. Bluvstein previously served as CFO of Argent BioPharma Ltd. (2024-2025) and G Medical Innovations Holdings Ltd. (2022-2024).
• · Mr. Bluvstein holds a Bachelor of Arts in Accounting and Economics from the Open University of Israel and is a CPA.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

01-06-2026

FS Bancorp, Inc. announced the appointment of Matthew D. Mullet as CEO effective June 1, 2026, as part of a previously disclosed succession plan. Joe Adams retired as CEO on May 31, 2026, but will remain a director. No financial metrics or performance data were provided in the filing.

• · Matt Mullet previously served as President and CEO of 1st Security Bank and President of the Company.
• · Matt Mullet served as CFO from 2011 before becoming President.
• · Joe Adams emphasized people-first culture and developed vision and purpose statements.
• · The Bank operates 28 branches, one headquarters, and loan production offices in Washington and Oregon.
• · The Bank services home mortgage customers across the Northwest, focusing on Washington markets.

01-06-2026

Magnolia Bancorp, Inc. (OTCQB: MGNO) announced a planned leadership transition effective June 1, 2026. Michael L. Hurley, who served Mutual Savings for over 42 years, stepped down as Chairman, President, and CEO to become Executive Chair of the Board of both Magnolia and Mutual Savings; Robert W. Kimbro assumed the roles of President and CEO of both entities. The company also established an Executive Committee comprising the Executive Chair, President and CEO, and CFO to oversee strategic objectives.

• · Mutual Savings is a federally chartered savings association with approximately $37 million in assets.
• · Magnolia Bancorp’s stock trades on the OTCQB market under symbol 'MGNO'.
• · The Executive Committee will include the Executive Chair, the President & CEO, and the Chief Financial Officer.
• · Michael L. Hurley served Mutual Savings for more than 42 years.
• · Robert W. Kimbro will oversee day-to-day operating activities including banking operations, customer service, lending, compliance, and organizational performance.

01-06-2026

The Federal Home Loan Bank of Pittsburgh announced the upcoming retirement of CFO Edward V. Weller, effective on or about October 20, 2026. The departure is planned and orderly, with the CFO continuing in his role until the retirement date. No successor or interim arrangement was disclosed in the filing.

• · CFO Edward V. Weller's retirement is effective on or about October 20, 2026.
• · Mr. Weller was identified as a named executive officer in the Bank's 2025 Form 10-K filed March 4, 2026.
• · The Bank has not announced a replacement or interim CFO arrangement.

01-06-2026

GRAIL, Inc. presented results from the NHS-Galleri trial and PATHFINDER 2 study at ASCO 2026. The NHS-Galleri trial, the first randomized controlled study of an MCED test, showed a clinically meaningful >20% reduction in Stage IV cancers in incident rounds and a 25% reduction in cancers diagnosed through emergency presentation. However, the primary endpoint of reducing combined Stage III and IV cancers was not met (incidence rate ratio 1.03, p=0.6234). PATHFINDER 2 demonstrated consistent performance with ~60% PPV, ~0.4% false positive rate, and >90% CSO accuracy across ~180,000 participants.

• · The primary endpoint of reducing combined Stage III and Stage IV cancers for 12 prespecified cancer types was not met (incidence rate ratio 1.03, p=0.6234).
• · In the first screening round, Stage III/IV cancers increased by 19% in the intervention arm vs control.
• · Stage IV cancers showed a 14% reduction across all rounds, with a 26% reduction in the third round + follow-up.
• · 16% more Stage I/II cancers were detected in the intervention arm.
• · The false positive rate over 3 rounds was 0.45% (864 false positives out of 71,128 participants).
• · Of the 303 false positives in the first round, 54 (17.8%) were subsequently diagnosed with cancer in later rounds, and 81% of those had a correct CSO prediction.
• · No serious study-related adverse events occurred.
• · In PATHFINDER 2, 85% of diagnostic evaluations were non-invasive, and less than 1% of participants had an invasive procedure.
• · Invasive procedures were more common in participants with cancer (91%) vs without cancer (50%).
• · Galleri detected many deadly cancers at early stages: >20% of colorectal, ~40% of lung, and ~70% of head & neck cancers were detected at Stage I or II.
• · The presentation includes forward-looking statements and risk factors referenced in the Form 10-Q for the period ended March 31, 2026.

01-06-2026

Credo Technology Group reported Q4 FY2026 revenue of $437.0M, up 7.4% QoQ and 157.0% YoY, with GAAP net income of $169.1M and non-GAAP net income of $226.7M. Full fiscal year 2026 revenue more than tripled to $1.34B, and non-GAAP net income increased over fivefold to $661.5M. However, GAAP gross margin slightly declined sequentially from 68.5% to 68.2%, and Q1 FY2027 revenue guidance of $465-475M implies a sequential growth slowdown to around 7-9%.

• · Q4 FY2026 GAAP operating expenses were $142.2M, non-GAAP operating expenses $81.7M.
• · Full year FY2026 GAAP operating income was $445.0M, non-GAAP operating income $638.8M.
• · Q1 FY2027 revenue guidance: $465M-$475M, GAAP gross margin 66.9%-68.9%, non-GAAP gross margin 67.0%-69.0%.
• · GAAP operating expenses guidance for Q1 FY2027: $167.6M-$171.6M, non-GAAP operating expenses: $86.0M-$90.0M.
• · Cash and short-term investments at end of FY2026: $1.4B, up from $431.3M at end of FY2025.
• · Goodwill and intangible assets of $92.8M and $29.3M respectively, reflecting acquisitions.

01-06-2026

On June 1, 2026, PSQ Holdings, Inc. filed an 8-K disclosing the departure of officer Michael Hebert, effective May 26, 2026, pursuant to a Severance Agreement and General Release. The filing includes the severance agreement as Exhibit 10.1 and a cover page interactive data file. No financial impact or replacement officer is detailed in this filing.

• · The severance agreement was entered into effective May 26, 2026.
• · Exhibit 10.1 is the Severance Agreement and General Release with Michael Hebert.
• · Exhibit 104 is the Cover Page Interactive Data File embedded in Inline XBRL.
• · No replacement officer or further succession details are mentioned in the filing.